Effectiveness and Cost of a Quantitative and Qualitative Nutritional Supplementation in Elderly Patients
NCT ID: NCT00560729
Last Updated: 2013-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE3
63 participants
INTERVENTIONAL
2003-10-31
2007-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
I
No interventions assigned to this group
II
oral nutrition
Renutryl 500
III
oral nutrition
Generique
IV
oral nutrition
Generique + Renutryl 500
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Renutryl 500
Generique
Generique + Renutryl 500
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age \> 70 years
* C reactive protein \> 30 mg/l
* 25 \< albumin \< 35 g/l
* 130 \< Na \< 145 mmol/l
* BMI \< 22
* weight loss \> 10 % within the last 6 months
* MNA \< 23.5
Exclusion Criteria
* severe digestive failure
* enteral or parenteral nutrition
* renal,cardiac or digestive failure
* lactose intolerance
* terminal phase severe pathology
* MMS \< 15
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Société des Produits Nestlé (SPN)
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christian Aussel, PhD
Role: STUDY_DIRECTOR
University PARIS V
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Georges Clemenceau
Champcueil, , France
Hopital Emile Roux
Limeil-Brévannes, , France
Hopital Charles RICHET
Villiers-le-Bel, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCNF 0402
Identifier Type: -
Identifier Source: org_study_id